Lynn Kurata, OD
Low Vision Rehabilitation · Santa Monica, CANPI 1841225158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 57.9% of the total. Reporting peaked in 2019 at $444 and has fallen 75.0% since, to $111 in 2025.
Across 17 payments — averaging $49.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$491
- Optovue, Inc.$96
- Bausch & Lomb Americas Inc.$81
- Rxsight Inc$72
- Tarsus Pharmaceuticals, Inc.$35
- Alcon$33
- plus $41 from 2 others
What the payments were for
- Food & beverage$81096%
- Education$182%
- Gifts$192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $491 |
| Optovue, Inc. | 2 | $96 |
| Bausch & Lomb Americas Inc. | 4 | $81 |
| Rxsight Inc | 1 | $72 |
| Tarsus Pharmaceuticals, Inc. | 1 | $35 |
| Alcon | 1 | $33 |
| Coopervision Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BTOD$261
- BIOTRUE ONE DAY$122
- INFUSE$122
How this compares
$848 in reported general payments places this provider in the 70th percentile of 37 low vision rehabilitation providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other low vision rehabilitation in Santa Monica
- Eric YoshinagaSanta Monica$799
- Lyly UngSan Francisco$9K
- Joseph LayaRedding$2K
- Shirley HongRowland Heights$2K
- Andrew PhillipsArcadia$1K
- Linda YeeSan Jose$1K
- Grace JengOakland$1K
- Tiffany ChanSan Francisco$1K
- Andy ChenLong Beach$1K
- David ShinFontana$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.